NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • About Patient and Public Involvement
      • Our Work with Patients and the Public
      • Learn More About Our Research
      • Patient Involvement Blog
      • External Links
    • For Patients, Carers and the Public
      • Current Listings for Involvement
      • REGISTER INTEREST
      • Patient and Public Involvement Workshops
    • PPI Resources for Researchers
      • PPI Strategy
      • A Researcher’s Guide to PPI
      • PPI Resources for Researchers
      • PPI Briefing Notes
      • PPI Case Studies
      • PPI Advisory Group
      • PPI Events for Researchers
      • Post a PPI Listing
      • Public Engagement for Researchers
      • Public Engagement Case Studies
  • Training Hub
    • Training Hub
    • Fellowships
    • Funding Opportunities
    • Clinical Researchers and Scientists
    • Nurses, Midwives and Allied Health Professionals
    • Next Generation Leaders Programme
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events
Research Theme

Surgical Innovation and Evaluation

You are here: Home > Research Themes > Surgical Innovation and Evaluation

Surgical Innovation and Evaluation

Innovations in surgery over the last few decades have led to tremendous improvements in the treatment of diseases and injuries. Examples include the development of minimally invasive procedures and robotic surgery, organ transplantation and regenerative cell therapies, prosthetics such as artificial joints and bionic devices, and gene therapy.

The objective of this theme is to establish a platform of multidisciplinary research projects promoting surgical technology innovation from proof-of-principle to large-scale evaluation. The research undertaken within the Surgical Innovation Theme falls broadly within the following areas:

  • Robotics and Electronic Devices: research in robotics and electronic devices aims to develop improved surgical procedures, as well as prosthetic devices for replacement of diseased or injured body parts.
  • Organ Reconditioning and Cell Therapies: research in organ reconditioning aims to improve the proportion of transplantable organs, and research in cell therapies explores cell transplantation and stem cell treatments for tissue regeneration.
  • Gene Therapy Surgery and Nanotechnology: research in gene therapy aims to develop efficacious treatments for previously incurable genetic diseases, and research in nanotechnology explores ways to enhance the delivery of chemotherapeutic agents to body tissues and organs.
  • Image-Guided Surgery: image-guided surgery explores the use of novel imaging technologies to improve surgical precision.

Watch

A robot has been used to inject a drug into the back of the eye in a world first for the next phase of a landmark clinical trial at Oxford’s John Radcliffe Hospital.  Prof Robert MacLaren used the remotely controlled robot to administer a tiny volume of blood dissolving agent tPA under the retina to treat a haemorrhage, an accumulation of blood in the eye that causes vision loss.  It is now hoped the robot can be used for other pioneering surgeries such as gene therapy, where a virus is delivered to replace missing genes that lead to loss of vision. The device has been developed by Preceyes BV, a Dutch medical robotics firm established by the University of Eindhoven, and is being trialled at the John Radcliffe by the University of Oxford. See news article

Surgical Innovation and Evaluation Theme

  • Introduction
  • Organ Reconditioning and Cell Therapies
  • Per-operative Imaging Study – Prostate Cancer
  • Contacts
  • Videos for this theme
  • News for this theme

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced bimonthly and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2021 NIHR Oxford Biomedical Research Centre

Cookies

This site uses cookies See our data control and privacy page